L02BA Anti-estrogens
ATC class of level 4 – chemical subgroup
This page lists the patient medication information or the product monograph for 18 drugs in this drug class and its subclasses.
- 18 prescription (Rx)
Place in the ATC system
- L Antineoplastic and immunomodulating agents 1,069 drugs
- L02 Endocrine therapy antineoplastic and immunomodulating agents 165 drugs
- L02B Hormone antagonists and related agents 146 drugs
-
L02BA Anti-estrogens 18 drugs
- L02BA01 Tamoxifen 6 drugs
- L02BA03 Fulvestrant 11 drugs
- L02BA05 Camizestrant 1 drug
-
L02BA Anti-estrogens 18 drugs
- L02B Hormone antagonists and related agents 146 drugs
- L02 Endocrine therapy antineoplastic and immunomodulating agents 165 drugs
Active ingredients of the class
- Camizestrant 1 drug
- Fulvestrant 11 drugs
- Tamoxifen (tamoxifen citrate) 6 drugs
Drugs in the class and its subclasses
Other classes of the same level
Other names of the drug class
- Czech: L02BA Antiestrogeny
- English (United Kingdom): L02BA Anti-estrogens
- French: L02BA antiestrogènes
- German: L02BA Antiestrogene
- Spanish: L02BA Antiestrogenos (terapia endocrina)
- German (Austria): L02BA Antiestrogene
- Italian: L02BA ANTIESTROGENI
- Polish: L02BA Antyestrogeny
- Turkish: L02BA anti-östrojenler
- Portuguese (Brazil): L02BA Anti-estrogénios
- Slovak: L02BA Antiestrogény
- German (Switzerland): L02BA Antiestrogene
- French (Switzerland): L02BA Antiestrogènes
- Italian (Switzerland): L02BA Antiestrogeni
- Dutch: L02BA Anti-oestrogenen
Sources
- Patient medication information and product monographs: Health Canada, Drug Product Database
- Active ingredients, ATC codes and Rx or OTC status: Health Canada, Drug Product Database
- World Health Organization (WHO): ATC/DDD system, class L02BA
Ask your doctor or pharmacist for advice.